UBS Group’s Citius Oncology, Inc. Common Stock CTOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $67.1K | Sell |
15,423
-34,322
| -69% | -$149K | ﹤0.01% | 6265 |
|
|
2025
Q1 | $46.3K | Buy |
49,745
+24,940
| +101% | +$23.2K | ﹤0.01% | 6360 |
|
|
2024
Q4 | $28.5K | Buy |
24,805
+23,173
| +1,420% | +$26.6K | ﹤0.01% | 6415 |
|
|
2024
Q3 | $2.27K | Buy |
+1,632
| New | +$2.27K | ﹤0.01% | 7256 |
|
|
2023
Q2 | – | Sell |
-1,504
| Closed | -$15.6K | – | 8527 |
|
|
2023
Q1 | $15.6K | Buy |
1,504
+1,104
| +276% | +$11.4K | ﹤0.01% | 6193 |
|
|
2022
Q4 | $4.06K | Buy |
+400
| New | +$4.06K | ﹤0.01% | 8197 |
|